Skip to main content
C&R Research Inc. logo

C&R Research Inc. — Investor Relations & Filings

Ticker · 359090 ISIN · KR7359090008 KO Professional, scientific and technical activities
Open in API
Filings indexed 163 across all filing types
Latest filing 2022-11-07 Major Shareholding Noti…
Country KR South Korea
Listing KO 359090

About C&R Research Inc.

https://www.cnrres.com/

C&R Research Inc. is a full-service Contract Research Organization (CRO) providing comprehensive clinical research services for pharmaceutical, biotechnology, and medical device companies. The company's offerings span the entire product lifecycle, from early-phase development and clinical trial design to regulatory affairs, data management, statistical consulting, and trial management. C&R Research is actively transitioning into a 'Data CRO' by integrating artificial intelligence (AI), Real-World Data (RWD), and platform-based solutions to enhance the efficiency and quality of clinical trials. The organization supports global studies, including navigating regulatory submissions with international bodies such as the U.S. FDA, and has demonstrated expertise in complex therapeutic areas like oncology, advanced biologics, and innovative medical devices.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details the acquisition of shares by a major shareholder (Yoon Moon-tae) and his special related parties in CNR Research. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2022-11-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). It details the share transactions (purchases) made by a director/major shareholder (Yoon Moon Tae) of CNR Research. This type of filing is a standard regulatory disclosure for insider trading/shareholding changes, which corresponds to the 'Director's Dealing' category.
2022-11-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by a major shareholder (Kolon Investment) in a listed company (CNR Research). This type of filing is specifically designed to notify the market and regulators of significant changes in shareholding levels, which falls under the 'Major Shareholding Notification' category.
2022-10-31 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by CNR Research. It details the contract value, duration, and nature of the agreement (clinical trial outsourcing). Since this is a specific regulatory disclosure of a material business event that does not fit into categories like financial reports, dividends, or management changes, it falls under the general regulatory filing category.
2022-10-12 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 씨엔알리서치' (C&R Research Inc.) covering the period from 2022.01.01 to 2022.06.30. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds into shares. It details the number of shares to be issued, the conversion price, and the remaining balance of convertible bonds. This type of corporate action, involving the issuance of new shares resulting from the conversion of debt, falls under the category of share issuance or capital changes.
2022-06-28 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.